Skip to main content
. 2015 Aug 20;63(7):779–784. doi: 10.7727/wimj.2013.264

Fig. 2. Serum transaminases levels.

Fig. 2

ALT: alanine transaminase; AST: aspartate transaminase; AZT: zidovudine; 3TC: lamivudine; f-APV: fosamprenavir

Note: data refer to mean values. At date of introduction of the last therapy with raltegravir and lamivudine, transaminases (especially ALT) had a high peak in serum; then they decreased until the last control, in September 2009, where they demonstrated an increase probably caused by HCV reinfection or raltegravir collateral effects.